Summary by Moomoo AI
Yichang East Sunshine Changjiang Pharmaceutical Co., Ltd. (“Dongguang Changjiang Pharmaceutical”) will hold its Annual General Meeting on June 7, 2024 at the company meeting room in Dongguan City, Guangdong Province, China. The meeting will consider a number of resolutions, including the approval of the Board's report for the year ended 31 December 2023, the Board of Supervisors reports, the consolidated financial statements and the annual report. In addition, the meeting shall hold the re-election and election of the members of the Board of Directors and the Board of Supervisors for the determination of the remuneration of the Directors. The meeting will also consider the decision to renew the Pimawy Accounting Firm as the company's auditor. To ensure that shareholders can attend and vote, the Company will suspend the registration of shares from 4 June to 7 June 2024. Details of all relevant resolutions and candidate information are available on the Company's website and the Exchange website for shareholders to access.